Whether pharmacological TREK-1 blockade (which is partial and reversible, unlike genetic knockout) carries seizure risk at therapeutic doses is unknown
XX wieku przez zesp Wadimira Khavinsona w petersburskim Instytucie Bioregulacji i Gerontologii, opiera si na zaoeniu, e krtkie peptydy mog peni funkcj czsteczek sygnaowych regulujcych aktywno tkanek
Unforeseen content matches that are irrelevant to the present study are almost inevitable in many SML studies
Options for managing tolerance include a brief dose reduction for 4 to 8 weeks ("drug holiday" at a lower dose, not complete cessation), lifestyle optimization to maximize the medication effect, evaluation for other contributing factors (thyroid function, cortisol, sleep quality, medication interactions), and consideration of adding a complementary compound to address specific aspects of the plateau
Philp D
The rule is simple: freeze lyophilized powder yes, freeze reconstituted solution no